Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
980.00    39.50 (4.20%)
Bid:
979.50
Ask:
980.50
Spread: 1.00 (0.102%)
Market Cap: £883.93m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Director Declaration

11 Mar 2026 12:00

RNS Number : 2538W
Gamma Communications PLC
11 March 2026
 

11 March 2026

 

Gamma Communications plc

 

Director Declaration

 

Gamma Communications plc ("Gamma" or "the Group"), a leading European provider of business-critical communication technology, announces, in compliance with UKLR 6.4.9R (2), that Rachel Addison, Senior Independent Director of the Company, has been appointed as a Non-Executive Director and Chair of the Audit Committee of AIM quoted Tapir Holdings Ltd with effect from today.

 

 

 

Enquiries:

 

Gamma Communications plc

Andrew Belshaw, Chief Executive Officer +44 (0)333 006 5972

Bill Castell, Chief Financial Officer

Rachael Matzopoulos, Company Secretary CompanySecretary@gamma.co.uk

 

Teneo (financial communications advisor)

James Macey White / Matt Low / Ollie Simmonds +44 (0) 207 260 2700

 

 

About Gamma

 

Gamma is a leading European provider of business-critical communications technology. Our extensive channel partner network connects major technology vendors with hundreds of thousands of SMEs, and we deal directly with large corporates and the public sector. Gamma combines its proprietary solutions with leading third-party cloud platforms, its own telecoms network and a high quality of service, to help customers communicate and collaborate more effectively.

 

Our broad and expanding portfolio - including cloud communications software (telephony, messaging, video, AI-driven customer experience), calling and network connectivity (including security) - enables customers of any size to deploy end-to-end communications and IT solutions via a single provider.

 

In mainland Europe, Gamma has its largest presence in Germany, delivering services to SMEs through both partners and its own self-service digital platform, and is recognised as one of the country's leading cloud communications providers.

 

Gamma Business serves UK SMEs via an extensive network of over 1,500 channel partners and its Service Provider business provides international calling capabilities for global communications platform and service providers.

 

For larger corporate and public sector organisations, Gamma Enterprise engages directly to design and support complex, integrated communications solutions.

 

With over 2,000 employees, Gamma is a FTSE 250 company listed on the London Stock Exchange (ticker: GAMA). More information can be found at: gammagroup.co

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNJBMBTMTIBBFF
Date   Source Headline
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 20232:25 pmRNSHolding(s) in Company
15th Aug 20234:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSTrading Statement
1st Aug 20237:00 amRNSTotal Voting Rights
13th Jul 20232:04 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:11 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:43 amRNSTotal Voting Rights
13th Jun 20235:03 pmRNSDirector/PDMR Shareholding
9th Jun 202312:35 pmRNSDirector/PDMR Shareholding
1st Jun 20232:19 pmRNSTotal Voting Rights - Replacement
1st Jun 202312:17 pmRNSTotal Voting Rights
30th May 202310:05 amRNSBlock Listing Application
25th May 20237:00 amRNSAppointment of Chair
23rd May 20234:12 pmRNSDirector/PDMR Shareholding
17th May 20235:08 pmRNSCommittee Composition
17th May 20234:25 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Trading update
15th May 202311:46 amRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSDirector/PDMR Shareholding
9th May 20239:44 amRNSBlock listing Interim Review
2nd May 202310:09 amRNSTotal Voting Rights
20th Apr 20234:33 pmRNSPublication of Notice of AGM
13th Apr 202311:31 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202311:42 amRNSDirector/PDMR Shareholding
28th Mar 202312:43 pmRNSHolding(s) in Company
21st Mar 20237:01 amRNSFinal Results
21st Mar 20237:00 amRNSChair succession planning
16th Mar 20237:00 amRNSDirectorate Change
14th Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20232:01 pmRNSTotal Voting Rights
1st Mar 20239:32 amRNSHolding(s) in Company
17th Feb 20237:30 amRNSDirector/PDMR Shareholding
1st Feb 20235:47 pmRNSTotal Voting Rights
27th Jan 202312:44 pmRNSHolding(s) in Company
18th Jan 20235:21 pmRNSHolding(s) in Company
17th Jan 202310:34 amRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSFull year growth expectations remain unchanged
11th Jan 20232:30 pmRNSTotal Voting Rights
11th Jan 20231:28 pmRNSHolding(s) in Company
10th Jan 202311:47 amRNSHolding(s) in Company
6th Jan 20234:08 pmRNSHolding(s) in Company
20th Dec 20227:00 amRNSChange of Senior Independent Director
19th Dec 202211:58 amRNSHolding(s) in Company
16th Dec 20223:31 pmRNSHolding(s) in Company
15th Dec 20226:26 pmRNSDirector/PDMR Shareholding
5th Dec 20225:15 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSChief Executive Officer Appointment
15th Nov 20226:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.